NanoString Technologies, Inc. (NASDAQ:NSTG) Releases FY17 Earnings Guidance

NanoString Technologies, Inc. (NASDAQ:NSTG) updated its FY17 earnings guidance on Tuesday. The company provided earnings per share guidance of ($2.20)-($2.03) for the period, compared to the Thomson Reuters consensus earnings per share estimate of ($2.33). The company issued revenue guidance of $114-$118 million, compared to the consensus revenue estimate of $108.47 million.

Several brokerages have recently weighed in on NSTG. Zacks Investment Research downgraded NanoString Technologies from a buy rating to a hold rating in a report on Saturday, August 12th. BidaskClub downgraded NanoString Technologies from a sell rating to a strong sell rating in a report on Friday, July 28th. Cowen and Company restated a buy rating on shares of NanoString Technologies in a report on Friday, July 14th. Finally, ValuEngine downgraded NanoString Technologies from a hold rating to a sell rating in a report on Thursday, July 13th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company. The stock currently has a consensus rating of Hold and a consensus price target of $18.50.

Shares of NanoString Technologies, Inc. (NASDAQ NSTG) traded down 0.22% during trading on Friday, hitting $13.88. The stock had a trading volume of 131,870 shares. The stock has a 50-day moving average price of $15.39 and a 200 day moving average price of $17.51. NanoString Technologies, Inc. has a 12 month low of $13.17 and a 12 month high of $23.45. The company’s market cap is $349.83 million.

NanoString Technologies (NASDAQ:NSTG) last announced its quarterly earnings data on Tuesday, August 8th. The biotechnology company reported ($0.20) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.17. The business had revenue of $34.59 million for the quarter, compared to analyst estimates of $29.87 million. NanoString Technologies had a negative return on equity of 329.59% and a negative net margin of 44.28%. Equities analysts expect that NanoString Technologies, Inc. will post ($2.12) EPS for the current fiscal year.

WARNING: This news story was originally posted by BBNS and is owned by of BBNS. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://baseballnewssource.com/markets/nanostring-technologies-inc-nasdaqnstg-updates-fy17-earnings-guidance-updated/1409848.html.

NanoString Technologies Company Profile

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Receive News & Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Kris Bryant Back in Spotlight, Cubs Pushing for Playoff Berth
Kris Bryant Back in Spotlight, Cubs Pushing for Playoff Berth
Despite Changes to Reduce The Length of Games, MLB Games are Actually Getting Longer
Despite Changes to Reduce The Length of Games, MLB Games are Actually Getting Longer
Despite Hitting Home Run, Judge Sets Longest Game Streak for Strikeouts
Despite Hitting Home Run, Judge Sets Longest Game Streak for Strikeouts
Los Angeles Dodgers Move 50 Games Over .500
Los Angeles Dodgers Move 50 Games Over .500
Miami’s Giancarlo Stanton Sets Marlins Home Run Record
Miami’s Giancarlo Stanton Sets Marlins Home Run Record
Bryce Harper Latest Star to Suffer Injury
Bryce Harper Latest Star to Suffer Injury


Leave a Reply

 
© 2006-2017 BBNS.